Research ArticleMolecular Imaging
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
Caroline Rousseau, David M. Goldenberg, Mathilde Colombié, Jean-Charles Sébille, Philippe Meingan, Ludovic Ferrer, Pierre Baumgartner, Evelyne Cerato, Damien Masson, Mario Campone, Aurore Rauscher, Vincent Fleury, Catherine Labbe, Alain Faivre Chauvet, Jean-Sebastien Fresnel, Claire Toquet, Jacques Barbet, Robert M. Sharkey, Loic Campion and Françoise Kraeber-Bodéré
Journal of Nuclear Medicine August 2020, 61 (8) 1205-1211; DOI: https://doi.org/10.2967/jnumed.119.236000
Caroline Rousseau
1Nuclear Medicine, ICO Cancer Center, Nantes, France
2CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France
David M. Goldenberg
3Immunomedics, Inc., Morris Plains, New Jersey
4IBC Pharmaceuticals, Inc., Morris Plains, New Jersey
Mathilde Colombié
1Nuclear Medicine, ICO Cancer Center, Nantes, France
Jean-Charles Sébille
1Nuclear Medicine, ICO Cancer Center, Nantes, France
Philippe Meingan
5Radiology, ICO Cancer Center, Nantes, France
Ludovic Ferrer
2CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France
6Physics, ICO Cancer Center, Nantes, France
Pierre Baumgartner
7Pharmacy, ICO Cancer Center, Nantes, France
Evelyne Cerato
8DRCI, University Hospital, Nantes, France
Damien Masson
9Biology Department, University Hospital, Nantes, France
Mario Campone
10Oncology, ICO Cancer Center, Nantes, France
Aurore Rauscher
7Pharmacy, ICO Cancer Center, Nantes, France
Vincent Fleury
1Nuclear Medicine, ICO Cancer Center, Nantes, France
Catherine Labbe
5Radiology, ICO Cancer Center, Nantes, France
Alain Faivre Chauvet
11Nuclear Medicine, University Hospital, Nantes, France
Jean-Sebastien Fresnel
10Oncology, ICO Cancer Center, Nantes, France
Claire Toquet
12Pathology Department, University Hospital, Nantes, France
Jacques Barbet
13GIP Arronax, Saint-Herblain, France; and
Robert M. Sharkey
3Immunomedics, Inc., Morris Plains, New Jersey
Loic Campion
2CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France
14Biometrics, ICO Cancer Center, Nantes, France
Françoise Kraeber-Bodéré
1Nuclear Medicine, ICO Cancer Center, Nantes, France
2CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France
11Nuclear Medicine, University Hospital, Nantes, France
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 8
August 1, 2020
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
Caroline Rousseau, David M. Goldenberg, Mathilde Colombié, Jean-Charles Sébille, Philippe Meingan, Ludovic Ferrer, Pierre Baumgartner, Evelyne Cerato, Damien Masson, Mario Campone, Aurore Rauscher, Vincent Fleury, Catherine Labbe, Alain Faivre Chauvet, Jean-Sebastien Fresnel, Claire Toquet, Jacques Barbet, Robert M. Sharkey, Loic Campion, Françoise Kraeber-Bodéré
Journal of Nuclear Medicine Aug 2020, 61 (8) 1205-1211; DOI: 10.2967/jnumed.119.236000
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
Caroline Rousseau, David M. Goldenberg, Mathilde Colombié, Jean-Charles Sébille, Philippe Meingan, Ludovic Ferrer, Pierre Baumgartner, Evelyne Cerato, Damien Masson, Mario Campone, Aurore Rauscher, Vincent Fleury, Catherine Labbe, Alain Faivre Chauvet, Jean-Sebastien Fresnel, Claire Toquet, Jacques Barbet, Robert M. Sharkey, Loic Campion, Françoise Kraeber-Bodéré
Journal of Nuclear Medicine Aug 2020, 61 (8) 1205-1211; DOI: 10.2967/jnumed.119.236000
Jump to section
Related Articles
Cited By...
- Antibody Engineering for Nuclear Imaging and Radioimmunotherapy
- Pretargeting: A Path Forward for Radioimmunotherapy
- Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
- Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy